As the Medical Lead, you will help shape and deliver the US Medical Affairs strategy for a priority hematology oncology indication. In this highly visible role, you will lead the Core Medical Team, develop and execute the integrated medical plan, and use scientific, clinical, customer, and multi-channel insights to inform evidence generation, product development, and launch readiness. You will collaborate across Medical, Clinical Development, Patient Safety, Commercial, Market Access, and Field Medical teams to advance science-driven strategies with meaningful impact for patients and the lymphoma community. Key responsibilities include managing a portfolio of investigator-initiated studies that complement the AstraZeneca clinical development plan, leading the real-world evidence strategy for the assigned indication or asset from concept through execution and communication, and creating the US publication plan for generated evidence. You will also provide medical review and input for key materials, engage strategic external partners, contribute to safety discussions, and support scientific exchange with field medical and key account teams.